Annual FCF
-$207.54 M
+$29.49 M+12.44%
December 31, 2022
Summary
- As of February 10, 2025, RETA annual free cash flow is -$207.54 million, with the most recent change of +$29.49 million (+12.44%) on December 31, 2022.
- During the last 3 years, RETA annual FCF has risen by +$46.29 million (+18.24%).
Performance
RETA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$70.20 M
+$11.39 M+13.96%
June 30, 2023
Summary
- As of February 10, 2025, RETA quarterly free cash flow is -$70.20 million, with the most recent change of +$11.39 million (+13.96%) on June 30, 2023.
- Over the past year, RETA quarterly FCF has dropped by -$18.81 million (-36.59%).
Performance
RETA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$249.46 M
-$18.81 M-8.15%
June 30, 2023
Summary
- As of February 10, 2025, RETA TTM free cash flow is -$249.46 million, with the most recent change of -$18.81 million (-8.15%) on June 30, 2023.
- Over the past year, RETA TTM FCF has increased by +$26.37 million (+9.56%).
Performance
RETA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RETA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.4% | -36.6% | +9.6% |
| 3 y3 years | +18.2% | +64.2% | +41.7% |
| 5 y5 years | -148.3% | -175.0% | +1.7% |
RETA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +14.2% | +49.8% | +75.4% | +20.2% | +12.2% |
| 5 y | 5-year | at high | +55.8% | +171.4% | +179.5% | +59.0% | +71.5% |
| alltime | all time | +958.9% | +55.8% | -2048.4% | +179.5% | +2752.9% | +71.5% |
Reata Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$70.20 M(-14.0%) | -$249.46 M(+8.2%) |
| Mar 2023 | - | -$81.59 M(+60.6%) | -$230.65 M(+11.1%) |
| Dec 2022 | -$207.54 M(-12.4%) | -$50.79 M(+8.4%) | -$207.54 M(-25.8%) |
| Sep 2022 | - | -$46.88 M(-8.8%) | -$279.87 M(+1.5%) |
| Jun 2022 | - | -$51.40 M(-12.1%) | -$275.83 M(+10.2%) |
| Mar 2022 | - | -$58.47 M(-52.5%) | -$250.30 M(+5.6%) |
| Dec 2021 | -$237.03 M(-26.7%) | -$123.13 M(+187.5%) | -$237.03 M(+48.7%) |
| Sep 2021 | - | -$42.83 M(+65.6%) | -$159.43 M(+1.6%) |
| Jun 2021 | - | -$25.87 M(-42.8%) | -$156.85 M(-52.1%) |
| Mar 2021 | - | -$45.20 M(-0.7%) | -$327.21 M(+1.2%) |
| Dec 2020 | -$323.27 M(+27.4%) | -$45.53 M(+13.1%) | -$323.27 M(-24.4%) |
| Sep 2020 | - | -$40.25 M(-79.5%) | -$427.37 M(-0.1%) |
| Jun 2020 | - | -$196.23 M(+375.6%) | -$427.78 M(+61.3%) |
| Mar 2020 | - | -$41.26 M(-72.4%) | -$265.19 M(+4.5%) |
| Dec 2019 | -$253.82 M(+200.5%) | -$149.63 M(+268.0%) | -$253.82 M(+78.7%) |
| Sep 2019 | - | -$40.66 M(+20.9%) | -$142.00 M(+44.5%) |
| Jun 2019 | - | -$33.64 M(+12.5%) | -$98.30 M(+9.0%) |
| Mar 2019 | - | -$29.89 M(-20.9%) | -$90.18 M(+6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$84.46 M(+1.0%) | -$37.81 M(-1343.6%) | -$84.46 M(+18.1%) |
| Sep 2018 | - | $3.04 M(-111.9%) | -$71.53 M(-23.7%) |
| Jun 2018 | - | -$25.52 M(+5.6%) | -$93.75 M(+9.4%) |
| Mar 2018 | - | -$24.17 M(-2.8%) | -$85.68 M(+2.5%) |
| Dec 2017 | -$83.60 M(+326.6%) | -$24.87 M(+29.6%) | -$83.60 M(+19.6%) |
| Sep 2017 | - | -$19.18 M(+9.9%) | -$69.93 M(+48.3%) |
| Jun 2017 | - | -$17.46 M(-21.0%) | -$47.14 M(+10.9%) |
| Mar 2017 | - | -$22.09 M(+97.3%) | -$42.49 M(+116.8%) |
| Dec 2016 | -$19.60 M(-56.3%) | -$11.20 M(-410.7%) | -$19.60 M(-6.5%) |
| Sep 2016 | - | $3.60 M(-128.1%) | -$20.96 M(-40.9%) |
| Jun 2016 | - | -$12.81 M(-1699.0%) | -$35.44 M(+0.3%) |
| Mar 2016 | - | $801.00 K(-106.4%) | -$35.35 M(-21.3%) |
| Dec 2015 | -$44.89 M(-49.5%) | -$12.56 M(+15.5%) | -$44.89 M(+38.8%) |
| Sep 2015 | - | -$10.88 M(-14.4%) | -$32.33 M(+50.7%) |
| Jun 2015 | - | -$12.71 M(+45.4%) | -$21.46 M(+145.4%) |
| Mar 2015 | - | -$8.74 M | -$8.74 M |
| Dec 2014 | -$88.81 M(+28.2%) | - | - |
| Dec 2013 | -$69.27 M | - | - |
FAQ
- What is Reata Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals annual FCF year-on-year change?
- What is Reata Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals quarterly FCF year-on-year change?
- What is Reata Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals TTM FCF year-on-year change?
What is Reata Pharmaceuticals annual free cash flow?
The current annual FCF of RETA is -$207.54 M
What is the all time high annual FCF for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high annual free cash flow is -$19.60 M
What is Reata Pharmaceuticals annual FCF year-on-year change?
Over the past year, RETA annual free cash flow has changed by +$29.49 M (+12.44%)
What is Reata Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of RETA is -$70.20 M
What is the all time high quarterly FCF for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high quarterly free cash flow is $3.60 M
What is Reata Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, RETA quarterly free cash flow has changed by -$18.81 M (-36.59%)
What is Reata Pharmaceuticals TTM free cash flow?
The current TTM FCF of RETA is -$249.46 M
What is the all time high TTM FCF for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high TTM free cash flow is -$8.74 M
What is Reata Pharmaceuticals TTM FCF year-on-year change?
Over the past year, RETA TTM free cash flow has changed by +$26.37 M (+9.56%)